What is cardio-oncology
Cardio-oncology is a service that delivers cardiac care to patients undergoing or with a history of receiving potentially cardio-toxic cancer treatments. Depending on where your patient is in their treatment, we work in partnership with the referring physician to ensure that treatment is completed without interruption. For patients who have completed treatment, we work with their general practitioner to ensure a long-term cardiovascular risk reduction plan is in place to maximise long term heart health for our patients.
Why are cardio-oncology clinics required to support cancer patients?
Significant emerging evidence has shown that cancer patients are at an increased risk of experiencing heart disease.1 This is due to a combination of treatment risk factors and shared risk factors between many common cancers and heart disease. By monitoring their heart during treatment and beyond, our team can identify those who do experience changes in heart function. Early identification has been shown to lead to the best outcomes for the patient.2 Monitoring heart health during potentially cardio-toxic treatments helps patients remain on their required treatment with no interruption. The goal of cardio-oncology is to anticipate issues related to cardiotoxicity and develop targeted prevention strategies in cancer patients.
Read real life patient case studies below.
What do they involve?
Who to refer?
All patients who have had or are currently undergoing cancer treatments that are potentially cardiotoxic should have a heart health check through our cardio-oncology clinics.
All patients undergoing or who have undergone thoracic irradiation (with exposure of the heart to ionising radiation) that have reasonable life expectancy should be considered for referral to a GenesisCare cardio-oncology service.
- Herceptin (Traztusumab)42
- Aromatase Inhibitors – Anastrozole, Letrozole, Exemestane5
- Androgen deprivation therapy6
- Tyrosine Kinase Inhibitors7
*not an exhaustive list